OS Therapies Inc
Close on Oct 19, 2026
- Market cap
- $55.76M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2025 Ended Jun 30, 2025 | Aug 19, 2025 | Before market open | – | $-0.19 | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 16, 2025 | After market close | – | $-0.18 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 31, 2025 | After market close | – | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 15, 2024 | After market close | – | $-0.18 | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 15, 2024 | After market close | – | $-0.26 | – |
Press releases
Announcements OS Therapies filed with the SEC
PRESS RELEASE ISSUED BY OS THERAPIES INCORPORATED ON OCTOBER 1, 2026
Material agreement · Executive or director change · Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY OS THERAPIES INCORPORATED ON JULY 2, 2026
Material agreement · New financial obligation · Unregistered share sale · Executive or director change · Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY OS THERAPIES INCORPORATED ON APRIL 30, 2026
Regulation FD disclosure · EX-99.1 to Form 8-K
SLIDE PRESENTATION DATED APRIL 30, 2026
Regulation FD disclosure · EX-99.2 to Form 8-K
PRESS RELEASE ISSUED BY OS THERAPIES INCORPORATED ON APRIL 2, 2026
Material agreement · Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY OS THERAPIES INCORPORATED ON JANUARY 12, 2026
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
INVESTOR PRESENTATION - OS THERAPIES INCORPORATED
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY OS THERAPIES INCORPORATED ON SEPTEMBER 2, 2025
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY OS THERAPIES INCORPORATED ON AUGUST 25, 2025
Agreement terminated · Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY OS THERAPIES INCORPORATED ON AUGUST 19, 2025
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY OS THERAPIES INCORPORATED ON JULY 14, 2025
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY OS THERAPIES INCORPORATED ON JUNE 23, 2025
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY OS THERAPIES INCORPORATED ON MAY 16, 2025
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED APRIL 9, 2025
Acquisition or disposition completed · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY OS THERAPIES INCORPORATED ON MARCH 31, 2025
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED JANUARY 29, 2025
Material agreement · Unregistered share sale · Executive or director change · Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY OS THERAPIES INCORPORATED ON DECEMBER 31, 2024
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, DATED DECEMBER 24, 2024
Material agreement · Unregistered share sale · Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY OS THERAPIES INCORPORATED ON NOVEMBER 15, 2024
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY OS THERAPIES INCORPORATED ON AUGUST 22, 2024
Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY OS THERAPIES INCORPORATED ON AUGUST 15, 2024
Results of operations · EX-99.1 to Form 8-K